Physician profile
Christina Bui
NPI 1538680046
$21,106.56
in general payments reported to CMS, 2019-2025
33 companies · $349 in 2025
The $349 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,088 · 2020: $1,302 · 2021: $5,424 · 2022: $7,618 · 2023: $2,934 · 2024: $1,391 · 2025: $349.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,231 · Food and Beverage: $1,444.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,230.97 |
| Food and Beverage | $1,443.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $7,607.41 | 2021-2024 | |
| Supreme Orthopedic Systems, LLC | $4,967.01 | 2021-2025 | |
| Stryker Corporation | $1,744.62 | 2019-2022 | |
| Novastep INC. | $1,200.61 | 2021-2025 | Nexis |
| Organogenesis INC. | $1,154.61 | 2019-2023 | Puraply |
| Orthofix Medical, INC. | $1,123.92 | 2019-2022 | |
| Cdc Medical LLC | $744.25 | 2020 | |
| Smith+Nephew, INC. | $657.58 | 2019-2025 | Collagenase Santyl, Grafix Pl, Renasys Go V2 Home |
| Arteriocyte Medical Systems, INC. | $258.19 | 2021 | |
| Zimmer Biomet Holdings, INC. | $209.90 | 2019-2021 | |
| Kerecis Limited | $191.77 | 2021-2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Misonix INC | $164.54 | 2019-2021 | |
| Celularity INC. | $112.00 | 2019 | |
| Horizon Therapeutics Plc | $108.10 | 2019 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $89.29 | 2021 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acumed LLC | $85.60 | 2020 | |
| Integra Lifesciences Corporation | $85.17 | 2020-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Paragon 28, INC. | $71.08 | 2019-2022 | |
| Treace Medical Concepts, INC. | $61.47 | 2025 | |
| Bioventus LLC | $60.72 | 2022-2025 | Exogen Ultrasound Bone Healing System |
| Arthrosurface Incorporated | $58.88 | 2019 | |
| Native Surgical, LLC | $56.64 | 2025 | |
| Next Science LLC | $52.21 | 2023-2024 | Surgx, Blastx, Xperience |
| Axogen | $36.96 | 2019 | |
| Mimedx Group, INC. | $32.61 | 2024 | |
| Ethicon US, LLC | $25.12 | 2020 | |
| Solventum Corporation | $24.76 | 2025 | Activ.A.C. |
| Acell, INC. | $24.57 | 2019 | |
| Nevro Corp. | $20.50 | 2023 | Senza |
| Musculoskeletal Transplant Foundation INC. | $20.30 | 2024 | |
| Triad Life Sciences INC. | $19.80 | 2022 | |
| Baxter Healthcare | $19.66 | 2019 | |
| Globus Medical, INC. | $16.71 | 2025 | Senza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christina Bui listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.